Showing results (1561-1570 of 1,644) with videos related to

Sort By:
Pageof 165
The Lancet. Child & Adolescent Health|September 29, 2023
Paediatric acute hepatitis of unknown aetiology: a national surveillance investigation in the USA during 2021 and 2022Jordan Cates, Julia M Baker, Olivia Almendares, et al.
The Journal of Clinical Investigation|July 28, 2015
Fibrinolysis is essential for fracture repair and prevention of heterotopic ossificationMasato Yuasa, Nicholas A Mignemi, Jeffry S Nyman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2016
Aberrant H3.3 dynamics in NAc promote vulnerability to depressive-like behaviorAshley E Lepack, Rosemary C Bagot, Catherine J Peña, et al.
Plos One|May 17, 2012
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferationDavid J DeGraff, Peter E Clark, Justin M Cates, et al.
Microbiology Spectrum|April 18, 2023
Point of Care CD4 Testing in National Household Surveys - Results and Quality Indicators from Eleven Population-Based HIV Impact Assessment (PHIA) SurveysSehin Birhanu, Frieda S Winterhalter, Paul Stupp, et al.
Biomedical Optics Express|October 1, 2019
Quantifying skin photodamage with spatial frequency domain imaging: statistical resultsJeffrey B Travers, Chien Poon, Trevor Bihl, et al.
Cancer Science|October 6, 2012
Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptorsNicholas A Mignemi, Doha M Itani, John H Fasig, et al.
Molecular Psychiatry|March 18, 2022
Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdoseOlivia Corradin, Richard Sallari, An T Hoang, et al.
Annals of Surgical Oncology|October 28, 2005
Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinomaJ Marc Pipas, Richard J Barth, Bassem Zaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2022
Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic MelanomaRichard P Tobin, Dasha T Cogswell, Victoria M Cates, et al.
Pageof 165